FDA awards 11 grants to clinical trials to develop new medical products for rare disease treatments
- Details
- Category: FDA

FDA approves innovative treatment for pediatric patients with congenital athymia
- Details
- Category: FDA

"Today's action marks the first FDA approval of a therapy to treat this very rare and devastating disease in children," said Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research.
FDA authorizes software that can help identify prostate cancer
- Details
- Category: FDA

FDA advances data, IT modernization efforts with new office of digital transformation
- Details
- Category: FDA

ECDC and EMA highlight considerations for additional and booster doses of COVID-19 vaccines
- Details
- Category: EMA

FDA approves first COVID-19 vaccine
- Details
- Category: FDA

FDA approves new treatment for Pompe disease
- Details
- Category: FDA

Patients with Pompe disease have an enzyme deficiency that leads to the accumulation of a complex sugar, called glycogen, in skeletal and heart muscles, which cause muscle weakness and premature death from respiratory or heart failure.
More Pharma News ...
- FDA approves first interchangeable biosimilar insulin product for treatment of diabetes
- FDA approves first oral blood thinning medication for children
- FDA grants accelerated approval for Alzheimer's drug
- FDA approves new drug treatment for chronic weight management, first since 2014
- FDA authorizes additional monoclonal antibody for treatment of COVID-19
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
- FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review